alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

Term ID

CHEBI:17725

Synonyms

(2R,4S,5R,6R)-5-acetamido-2-{[(2R,3R,4S,5R,6S)-6-{[(2R,3S,4R,5R,6R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
(N-acetylneuraminosyl(alpha2-6)lactosamine)
5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->6)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranose
6'-Sialyllactosamine
6-Sialyllactosamine
alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
alpha-N-Acetylneuraminyl-2,6-beta-delta-galactosyl-1,4-N-acetyl-beta-delta-glucosamine
alpha-NeuNAc-(2->6)-beta-D-Gal-(1->4)-beta-D-GlcNAc
alpha-NeupNAc-(2->6)-beta-D-Galp-(1->4)-beta-D-GlcpNAc
N-Acetylneuraminosyl(alpha2-6)lactosamine
Neu5Aca2-6Galb1-4GlcNAcb
Neu5Acbeta2-6Galbeta1-4GlcNAcbeta
Neuac-lact
NeuAcalpha2,6Galbeta1,4GlcNAc
Neuacalpha2,6GalNAcbeta1,4GlcNAc
Neuacalpha2-6Galbeta1-4GlcNAcbeta
O-(N-Acetyl-a-neuraminosyl)-(2->6)-O-b-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-b-D-Glucopyranose
O-(N-Acetyl-alpha-neuraminosyl)-(2->6)-O-beta-delta-galactopyranosyl-(1->-4)-2-(acetylamino)-2-deoxy-beta-delta-Glucopyranose
O-(N-Acetyl-alpha-neuraminosyl)-(26)-O-beta-D-galactopyranosyl-(1->-4)-2-(acetylamino)-2-deoxy-beta-D-Glucopyranose
O-5-(acetylamino)-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulopyranonosyl-(2->6)-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranose

Definition

An amino trisaccharide consisting of an N-acetyl-α-neuraminyl residue attached to the galactose residue of N-acetyllactosamine via an α-(2→6)-linkage.

References

beilstein:5721087
cas:64364-50-7
glygen:G73578JC
glytoucan:G73578JC
hmdb:HMDB0001081
kegg.compound:C04886
metacyc.compound:ALPHA-N-ACETYLNEURAMINYL-26-BETA
pubmed:10619708
pubmed:10683228
pubmed:10940350
pubmed:11425186
pubmed:11685546
pubmed:12954214
pubmed:19443021
pubmed:25568069
pubmed:31537530

Ontology

ChEBI ( EBI )

Resources

CTD

Relationships

Phenotype

Phenotype resulting from alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

Phenotype where environments contain alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

Phenotype modified by environments containing alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

Phenotype affecting alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine

Human Disease Model